Trastuzumab Withdrawn Phase 0 Trials for Neurologically Stable / Advanced Solid Tumors / Metastatic Brain Tumors / Documented Her2 Overexpression Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment0
clinicaltrials.gov IdentifierTitleDrugs
NCT0273579864-Cu Labeled Brain PET/MRI for MM-302 in Advanced HER2+ Cancers With Brain Mets